C07D 263/24
With hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon
Official title: with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
C07D263/24 (With hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon) appears on 264 US grants and 212 published applications in this corpus.
Search patents in C07D- Granted patents
- 264
- Published applications
- 212
- Assignees
- 177
- Inventors
- 851
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 9 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 11 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 0 |
| 2002 | 11 | 11 |
| 2003 | 8 | 12 |
| 2004 | 9 | 14 |
| 2005 | 3 | 11 |
| 2006 | 6 | 9 |
| 2007 | 7 | 6 |
| 2008 | 7 | 8 |
| 2009 | 5 | 13 |
| 2010 | 7 | 11 |
| 2011 | 7 | 5 |
| 2012 | 2 | 5 |
| 2013 | 4 | 7 |
| 2014 | 6 | 9 |
| 2015 | 4 | 14 |
| 2016 | 10 | 12 |
| 2017 | 11 | 6 |
| 2018 | 5 | 12 |
| 2019 | 8 | 8 |
| 2020 | 5 | 6 |
| 2021 | 3 | 3 |
| 2022 | 5 | 9 |
| 2023 | 3 | 8 |
| 2024 | 4 | 6 |
| 2025 | 7 | 7 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Industrial synthesis of serinol6 Oct 2026US 12,753,146 B2Bracco Imaging S.P.A.
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors6 Jan 2026US 12,516,046 B2Merck Sharp & Dohme Corp.
- Hepatitis B antiviral agents16 Dec 2025US 12,496,282 B2Enanta Pharmaceuticals, Inc.
- Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl]ethenone28 Oct 2025US 12,454,512 B2Eli Lilly and Company
- A bicyclopentyl thianthrenium compound, process for preparing the same and the use thereof25 Dec 2025US 2025/0388561 A1Studiengesellschaft Kohle gGmbH
- Process for the preparation of 4-substituted 2-oxazolidinones23 Oct 2025US 2025/0326724 A1Syngenta Crop Protection AG
- Synthesis methods of acyl chain of qs-21 and derivative thereof4 Sep 2025US 2025/0276992 A1Obi Pharma, Inc.
- Compounds for enhancing read through of genes containing premature termination codons and methods for making and using the same17 Jul 2025US 2025/0228865 A1Sanofi US Services Inc.
- Anti-inflammatory and analgesic compounds and use thereof24 Apr 2025US 2025/0129012 A1Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents88US 4,948,801 AE. I. Du Pont de Nemours and Company · 1990
- Saccharide intermediates in the formation of the calicheamicin and esperamicin oligosaccharides86US 5,384,412 AThe Scripps Research Institute · 1995
- Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents75US 4,705,799 AE. I. Du Pont de Nemours and Company · 1987